SenesTech, Inc. (SNES)
| Market Cap | 3.74M -74.0% |
| Revenue (ttm) | 2.78M +20.9% |
| Net Income | -7.66M |
| EPS | -1.44 |
| Shares Out | 5.42M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 89,965 |
| Open | 0.6500 |
| Previous Close | 0.6540 |
| Day's Range | 0.6500 - 0.7726 |
| 52-Week Range | 0.5500 - 3.0300 |
| Beta | 0.11 |
| Analysts | n/a |
| Price Target | 7.50 (+986.96%) |
| Earnings Date | Nov 10, 2026 |
About SNES
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the act... [Read more]
Financial Performance
In 2025, SenesTech's revenue was $2.22 million, an increase of 19.60% compared to the previous year's $1.86 million. Losses were -$6.38 million, 3.22% more than in 2024.
Financial StatementsAnalyst Summary
The average 12-month stock price target for SNES is $7.5, which is an increase of 986.96% from the latest price.
News
SenesTech Appoints JoAnna Abrams to Board of Directors
SURPRISE, Ariz., Nov. 17, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), an innovator in responsible rodent population management, today announced the appointment of JoAnna Abrams to its Boa...
SenesTech Earnings Call Transcript: Q3 2026
Q3 revenue reached a record $1.1m, supported by rapid e-commerce and subscription growth and higher direct B2B sales. Gross profit set a record while operating cash use declined for a third consecutive quarter.
SenesTech Earnings release: Q3 2026
SenesTech released its Q3 2026 earnings on November 10, 2026, summarizing the period's financial results.
SenesTech Quarterly report: Q3 2026
SenesTech has published its Q3 2026 quarterly earnings report on November 10, 2026.
SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth
Revenue increased 42% sequentially as e-commerce and subscriptions expanded;Ā Gross profit reached a record $796,000 SURPRISE, Ariz., Nov. 10, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), ...
SenesTech to Report Third Quarter 2026 Financial Results on Tuesday, November 10, 2026
Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time
SenesTech Expands E-Commerce Reach Through Walmart Fulfillment Services
Enhanced convenience and nationwide fulfillment support SenesTech's growing ecommerce business Enhanced convenience and nationwide fulfillment support SenesTech's growing ecommerce business
SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
Portland-Based Experts on Brand and Marketing Strategy Will Help SenesTech Pursue E-Commerce and B2B Sales-Growth Opportunities Portland-Based Experts on Brand and Marketing Strategy Will Help SenesTe...
Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
SURPRISE, Ariz., Oct. 28, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent control, today announced that it has engaged Portland, Oregon-based Sandstrom Partners, Inc. (...
SenesTech Receives Nasdaq Minimum Bid Price Notification and Highlights Record Third Quarter Revenue
SURPRISE, Ariz., Oct. 22, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that, on Oct. 20, 20...
SenesTech shareholder crosses 30% ownership, issues letter
Glenbrook, a shareholder of SenesTech (SNES), and owners of over 30% of outstanding shares of the company, issued the following letter: āI am writing to advise you that Glenbrook Capitalā¦
GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH
Glenbrook Believes Better Market Strategy and Sharpened Capitalization Focus Would Create Significant Upside MINDEN, Nev., Oct. 19, 2026 /PRNewswire/ -- Glenbrook Capital Management ("Glenbrook"), a l...
SenesTech reports 88% reduction in rat activity in Chicago pilot
SenesTech (SNES) announced results from a pilot of Evolve Rat Birth Control in Chicagoās Wicker Park Bucktown Special Service Area #33. Over a 12-month monitoring period, standardized tracking-tunnel ...
SenesTech Reports 88% Reduction in Rat Activity in Chicago Pilot, Building on Record $1.1 Million Quarterly Revenue Milestone
Rodent-Related 311 Calls in Deployment Area Fell 36% While Citywide Calls Increased EvolveĀ® Rat Bith Control TM Expands to Six Chicago-Area SSAs and Wards SURPRISE, Ariz., Oct. 19, 2026 (GLOBE NEWSWIR...
SenesTech reports preliminary Q3 revenue $1.1M
Two estimates $797,000. Preliminary third quarter 2026 revenue was approximately $1.1M, representing approximately 40% growth compared with the second quarter of 2026 and approximately 55% growth comp...
SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth
Preliminary Revenue of $1.1 Million is the Highest Quarterly Revenue in the Company's History SURPRISE, Ariz., Oct. 15, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth ...
SenesTech Transcript: Lytham Partners Fall 2026 Investor Conference
A new commercial strategy drove record revenue, margins, and subscriptions, with e-commerce and Amazon sales surging after bringing channels in-house. Regulatory trends and proven field results support a large, growing market, while a three-engine growth plan and disciplined execution position the company for scalable, profitable expansion.
SenesTechās Evolve to launch through Grove Collaborativeās online marketplace
SenesTech (SNES) announced that its Evolve family of rodent birth control products will soon be available through Grove Collaborativeās online marketplace. The launch will expand consumer access to an...
SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control⢠Products to Sustainability-Focused Consumers
SURPRISE, Ariz., Sept. 23, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its EvolveĀ® family...
SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference
PHOENIX, Sept. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, will participate in a webcast presentation and ...
SenesTech Slides: Investor presentation
SenesTech has posted slides in relation to its latest quarterly earnings report, which was published on September 11, 2026.
SenesTech announces six-month deployment of Evolve Rat
SenesTech (SNES) announced that a six-month deployment of Evolve Rat as part of a comprehensive Integrated Pest Management program reduced measured rodent activity by 43% at a municipal facility inā¦
Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with EvolveĀ® Rat
SURPRISE, Ariz., Aug. 31, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that a six-month deploym...
SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SURPRISE, Ariz., Aug. 27, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Direct...
SenesTech Transcript: Lytham Partners 2026 Consumer & Technology Investor Summit
A new corporate strategy and leadership overhaul have driven record revenue, e-commerce, and subscription growth, with a focus on profitable scaling and B2B expansion. Product innovation and assessment services are enhancing customer value, while financial discipline supports a path to cashflow break-even.